Praxis Precision Medicines

This study tests whether a new drug, vormatrigine, can safely reduce the number of focal seizures in adults with epilepsy. About 300 participants who already take 1 to 3 seizure medications will receive either vormatrigine or a placebo. The main goal is to see if the drug lowers …

This study tests a new medicine called elsunersen in 50 children with a rare genetic epilepsy caused by changes in the SCN2A gene. The goal is to see if the drug can safely reduce the number of seizures. Children must have had seizures before 3 months of age and currently have at…

This study tests an experimental drug called relutrigine in 160 people with a severe, early-onset epilepsy called developmental and epileptic encephalopathy (DEE). The goal is to see if the drug can safely reduce monthly seizures compared to a placebo. After the main study, all p…